More Xarelto Lawsuits Have Been Filed
Xarelto has been linked to serious side effects including internal bleeding, gastrointestinal bleeding, brain bleed and death.
Lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over Xarelto have been consolidated in Louisiana federal court.
To date, nearly 19,000 individual lawsuits have been filed in the Xarelto federal multi-district litigation against Bayer, Johnson & Johnson and Janssen Pharmaceuticals -- the manufacturers and sellers of Xarelto. Another 2,000 Xarelto cases are pending in the Philadelphia Court of Common Pleas as part of a Pennsylvania state court consolidated proceeding.
On December 5, 2017, a jury in the Philadelphia Court of Common Pleas returned a unanimous verdict against the makers of Xarelto (Bayer and Johnson & Johnson and Janssen Pharmaceuticals) in the amount of $27.8 million dollars. The verdict for Plaintiff Lynn Hartman included $1.8 million in compensatory damages and $26 million dollars in punitive damages. At trial, in addition to proving that Xarelto caused her internal bleeding, Ms. Hartman presented evidence that Xarelto’s label failed to adequately warn about the risks of taking Xarelto with Aspirin, which Defendants knew to increase the risk of bleeding by 93 percent. There was also evidence that Xarelto’s label failed to inform doctors that Xarelto’s clinical trials showed a 50 percent increased risk of bleeding for patients taking Xarelto in the U.S. compared to patients in other countries.
If you feel you may have been harmed by a pharmaceutical product you are using please see your doctor first then call a personal injury attorney that specializes in bad drugs litigation. If you are around or near Columbus, MS call 205-342-3622 or Tuscaloosa, AL call 662-328-9365 or email lawyerharmon@gmail.com
Lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over Xarelto have been consolidated in Louisiana federal court.
To date, nearly 19,000 individual lawsuits have been filed in the Xarelto federal multi-district litigation against Bayer, Johnson & Johnson and Janssen Pharmaceuticals -- the manufacturers and sellers of Xarelto. Another 2,000 Xarelto cases are pending in the Philadelphia Court of Common Pleas as part of a Pennsylvania state court consolidated proceeding.
On December 5, 2017, a jury in the Philadelphia Court of Common Pleas returned a unanimous verdict against the makers of Xarelto (Bayer and Johnson & Johnson and Janssen Pharmaceuticals) in the amount of $27.8 million dollars. The verdict for Plaintiff Lynn Hartman included $1.8 million in compensatory damages and $26 million dollars in punitive damages. At trial, in addition to proving that Xarelto caused her internal bleeding, Ms. Hartman presented evidence that Xarelto’s label failed to adequately warn about the risks of taking Xarelto with Aspirin, which Defendants knew to increase the risk of bleeding by 93 percent. There was also evidence that Xarelto’s label failed to inform doctors that Xarelto’s clinical trials showed a 50 percent increased risk of bleeding for patients taking Xarelto in the U.S. compared to patients in other countries.
If you feel you may have been harmed by a pharmaceutical product you are using please see your doctor first then call a personal injury attorney that specializes in bad drugs litigation. If you are around or near Columbus, MS call 205-342-3622 or Tuscaloosa, AL call 662-328-9365 or email lawyerharmon@gmail.com
Comments
Post a Comment